InvestorsHub Logo
Followers 39
Posts 2472
Boards Moderated 0
Alias Born 10/06/2000

Re: geodan post# 1085

Tuesday, 04/25/2017 7:49:53 PM

Tuesday, April 25, 2017 7:49:53 PM

Post# of 1475
Q4 profits were expected to be much higher but GEHC deliveries were down and VasoHealthcare IT expenses were up.

Its important to realize VasoHealthcare IT is just getting started. 2016 sales were $1.9Mil(up from $500K in 2015) but this should start gaining traction and start contributing to profits instead of eating them up.

VasoHealthcare IT backlog is $7.4Mil and as sales continue to grow so will Netwolves sales. The company is selling Netwolves products to these same costumers.

The GEHC deliveries is not a sign of weakness in the market, actual sales were up YOY so this segment should have strong results in 2017.

The company has stated the VasoHealthcare IT segment should pass the break even point "soon" and that they expected improvements in the medical device segment in 2017. If they can deliver this should be much higher in the near future.

Also cash is up to $8Mil so another acquisition would not surprise me.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VASO News